ANRO
Alto Neuroscience, Inc.
NYSE · Healthcare · Biotechnology · US
$35.55
−2.34%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-38.4%
Return on equity
-33.2%
Return on assets
19.6%
Return on invested capital
0.00x
Asset turnover
-$68.3M
Cash from operations
$6.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026